news.cision.com

Biohit Oyj, Other information disclosed according to the rules of the Exchange, June 16, 2022 at 9:30 am local time (EEST) Biohit Oyj’s Board of Directors has in its meeting yesterday (June 15) elected PhD Lea Paloheimo as the Chairman of the Board of Directors. Paloheimo has been Member of the Board of Directors of Biohit Oyj since 2019. She worked with Biohit Oyj in 2001-2019, for example as Production, Product Development and Quality Director, as well as Business Development Director. Additional information: CEO Päivi Siltala, Biohit Oyj tel. +358 9 773 861 investor.

Subscription period in Scandion Oncology Rights Issue of up to approximately SEK 93.7 million commences

The Rights Issue is also open for subscriptions to the public.NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE. Scandion Oncology (Scandion or “The Company”), a biotech company developing first-in-class medicines aimed at treating cancer which is resistant to current treatment options,

Pingday once again chooses Waystream's accesswitches

Press release 16 June 2022 Through its long-standing partner, NetNordic Sweden, Waystream has signed a multi-year agreement with Pingday (formerly Öresundskraft). The agreement is in the MSEK 10 range, and involves the replacement and modernisation of existing access equipment over three to five years.Pingday, which is a wholly owned subsidiary of Öresundskraft AB and the City of Helsingborg, operates, among other things, the Open City Network, the fibre network, the City Hub for IoT, and several operator hotels. The ambition is high: to become Europe's leading regional city network! In

Implantica receives Frost & Sullivan’s 2022 European Technology Innovation Leadership Award for RefluxStop™ – an Innovative Treatment Solution for Acid Reflux

Implantica AG (publ), a med-tech company at the forefront of the upcoming eHealth revolution, announces today that Frost & Sullivan, world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, announced today that Implantica was named the winner of the 2022 European Technology Innovation Leadershiop Award for its novel RefluxStop™ technology treating gastroesophageal reflux disease (GERD).“Frost & Sullivan commends Implantica’s development of its groundreaking technology, RefluxStop™, a medical implant

Mandatory notification of trade

Magdalena Kadziolka, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 15th June 2022, acquired interests in shares of Otello Corporation ASA. The balance of Magdalena Kadziolka and related parties’ holdings after the transaction totals 28,555,688 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

Aker Solutions, Siemens Energy and Doosan Babcock Awarded FEED Contract for Keadby 3 Carbon Capture Power Station

June 16, 2022 – A consortium of Aker Solutions, Siemens Energy and Doosan Babcock has been awarded the front-end engineering and design (FEED) contract for SSE Thermal and Equinor’s proposed Keadby 3 Carbon Capture Power Station, which could become the UK’s first power station with carbon capture and storage.Over the next 12 months, the consortium will deliver the engineering design for the proposed plant – with a generating capacity of up to 910MW – that is to be equipped with a carbon-capture plant to remove CO2 from its emissions. Aker Carbon Capture will be the consortium’s carbon-

Bonava sells a total of 137 rental apartments in Finland

Bonava is selling 76 rental apartments in Turku, Finland, to the investor Taaleri and 61 rental apartments in Tampere to the investor eQ. The transactions amount to EUR 27 million and the first housing units are expected to be completed and handed over to the customer in the third quarter of 2023.– It is gratifying to present these transactions, which will deepen the partnerships we have with Taaleri and eQ. Together, we are creating opportunities for hundreds of people to live in a happy neighbourhood, says Riku Patokoski, Business Unit President, Bonava Finland. Kirstinpuisto, a

Hyperco purchases a data center property in Helsinki Metropolitan Area – Extension potential for new developments

Hyperco, a Finland-based real estate investment firm focused on acquiring and developing data centers, has acquired a data center property located in the Helsinki Metropolitan Area.[A picture containing grass, sky, outdoor, railroad Description automatically generated] Hyperco has acquired the property from TS-Yhtymä, a Finnish family office, at a total transaction value of over EUR 35 million. The property is located at Myllynkivenkuja 4 in Vantaa. Hyperco’s investors include NREP, one of the largest real estate funds in the Nordics, and Varma, one of Finland’s largest pension

Echandia to supply battery system for a second emission-free high-speed catamaran for commercial traffic in Stockholm

Swedish Echandia, a leading developer of heavy-duty energy solutions for maritime electrification, has received a second order from Green City Ferries AB. Green City Ferries is expanding its waterborne public transport in Stockholm with another ambitious zero-emission Beluga24 vessel. The Beluga24 is the world’s first fully emission-free, high-speed, carbon fiber catamaran, and Echandia has been chosen to provide energy solutions for the vessels. The order is worth approximately SEK 7.5 million.Late last year, Echandia announced its first order for a fuel cell energy solution to power the

Increased order intake and market growth in the European biogas market

BPC Instruments AB ("BPC Instruments" or "BPC") has just received a large purchase order for delivery of six complete AMPTS[®] Systems with a total order value of 1,7 MSEK.In recent months BPC Instruments has received a significant increase in purchase demand for AMPTS[®] from the European biogas sector, including a record-high value purchase agreement for six complete systems from a Danish leading green transition and biogas pioneer. Together with other orders and a strong sales pipeline from other clients, we see a strong trend of market growth for our flagship instrument AMPTS[®] in

Vicore announces first human dosed with novel ATRAG, C106

· First healthy volunteer dosed with C106 in a phase 1 trial · C106 is the first new angiotensin II type 2 receptor agonist (ATRAG) from Vicore’s VP03 program · Topline data expected Q1 2023 Gothenburg, June 16, 2022 - Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting the angiotensin II type 2 receptor (AT2R), today announces initiation of a first-in-human trial with the novel ATRAG C106. The trial is expected to read out during Q1 2023. Vicore’s C106 is the first of four advanced candidate drugs from the VP03

Balder and Stockholms Travsällskap in new collaboration on the development of Solvallastaden

Fastighets AB Balder and Stockholms Travsällskap (Stockholm Trotting Society) are starting a joint venture company with the intention of developing a further three blocks and 500 apartments in Solvallastaden.In 2018, Balder acquired approximately 83,000 sqm of building rights in the Solvallastaden development area. Now the company is strengthening its position by acquiring a further approximately 50,000 sqm together with Stockholms Travsällskap for housing and commercial services. Taken together, the property company Balder has building plans for nine blocks involving around 1,300

The innovative value chain enables the utilization of label waste as a raw material for building insulation

Thu, Jun 16, 2022 07:59 CET

(UPM Raflatac, Helsinki, 16 June 2022 at 9:00 EEST) – The unique circular economy value chain enables the recycling of label release liner waste, ensures the supply of PET raw material to a Finland based chemical company Inosence Polyol Oy and increases the share of recycled raw material in Finnfoam's insulation production. UPM Raflatac, Inosence Polyol Oy and Finnfoam have built an innovative collaboration model that improves the resource efficiency. The PET plastic label liner waste collected through UPM Raflatac RafCycle[TM] recycling service forms a waste stream which is

Adelis successfully exits Knightec

Adelis Equity Partners Fund I (“Adelis”) has divested its majority stake in Knightec, a leading technology and digitalisation consultant, to investment company Ratos. The transaction values Knightec at an EV of SEK 1,625 million.Adelis invested in Knightec in 2017 in partnership with Dimitris Gioulekas, founder and CEO, along with a large number of key employees. During Adelis’ ownership, Knightec doubled its revenue to SEK 941 million whilst tripling EBITA to 140m and reaching an industry-leading margin of 15%. This has been achieved thanks to a focused growth strategy within areas such as

Skanska buys land in Ale Municipality, Sweden, for about SEK 300M

Thu, Jun 16, 2022 07:30 CET

Skanska has acquired approximately 236,000 square meters of land in Ale Municipality outside Gothenburg, Sweden, for about SEK 300M. The seller is Björk Invest i Göteborg AB. The transfer of the property will take place when the zoning plan is finally approved.On the land plot, Skanska and BoKlok plan to develop homes with high sustainability ambitions. The building right will include approximately 600 homes with associated community services.

Wihlborgs lets 4,200 square metres at Ideon in Lund

Thu, Jun 16, 2022 07:30 CET

Wihlborgs has signed agreements with three tenants for a total of 4,200 square metres at the Nya Vattentornet 4 (“Cube”) property at Ideon. One of the new tenants is MAX IV (Lund University), which moves in on 1 October.The activities of the MAX IV national laboratory are expanding and thus so is their need for office space. Lund University is therefore renting 1,000 square metres in Cube on behalf of MAX IV, primarily for support functions and also for remote research and monitoring. Other tenants who have recently signed leases at the property include a SaaS (Software as a Service)

Outokumpu concludes the first phase of the strategy ahead of time – announces the second phase, related new appointments and financial targets with the aim of strengthening the core

Thu, Jun 16, 2022 07:15 CET

Outokumpu OyjStock exchange releaseJune 16, 2022, at 8.15 am EESTOutokumpu concludes the first phase of the strategy ahead of time – announces the second phase, related new appointments and financial targets with the aim of strengthening the core Outokumpu has successfully completed the first phase of the strategy with a strong focus on de-risking the company and strengthening the balance sheet. The first phase of the three-phase strategy was focused on three key priorities: Commercial Excellence, Cost and Capital Discipline and Lean and Agile Organization. The company has made

Outokumpu updates its dividend policy

Thu, Jun 16, 2022 07:14 CET

Outokumpu OyjStock exchange releaseJune 16, 2022 at 8.14 am EESTOutokumpu updates its dividend policy The Board of Directors (“the Board”) of Outokumpu Oyj has resolved on a new dividend policy. According to the new dividend policy Outokumpu aims to distribute a stable and growing dividend, to be paid annually. “Outokumpu aspires to be an attractive investment for long-term investors. The updated dividend policy aims to provide for stability and predictability, despite the volatile nature of the stainless steel business”, says Chairman of the Board Kari Jordan. According to

Koskenkorva distillery to run on local wind power

Fortum and Anora have signed a wind power supply agreement regarding the Kalax wind farm in Närpiö. The deal will allow up to half of the electricity used by Anora at the Koskenkorva distillery to be replaced by local wind power. The agreed-upon collaboration will continue through 2023–2025.Wind power is one of the most important sources of renewable energy for the future, and the conditions for wind power production in Finland are excellent. The Kalax wind farm, with a total capacity of 90 MW, was commissioned in 2021 and consists of 21 wind turbines. “Climate change mitigation and

Nanochannels light the way towards new medicine

To develop new drugs and vaccines, detailed knowledge about nature’s smallest biological building blocks – the biomolecules – is required. Researchers at Chalmers University of Technology, Sweden, are now presenting a groundbreaking microscopy technique that allows proteins, DNA and other tiny biological particles to be studied in their natural state in a completely new way. A great deal of time and money is required when developing medicines and vaccines. It is therefore crucial to be able to streamline the work by studying how, for example, individual proteins behave and

Ratos carries out major investment in new platform – acquires majority stake in Knightec

Ratos has signed an agreement to acquire 70% of the consulting company Knightec, thereby entering into a partnership with co-founder and CEO Dimitris Gioulekas. Over the past 12 months, Knightec had sales of SEK 941m, with adjusted EBITA of SEK 140m. The cash-free, debt-free purchase price for 100% of the company (enterprise value) amounts to SEK 1,625m, corresponding to a multiple of 11.6 (EV/EBITA).Knightec was founded in 2003 and has experienced strong growth ever since, mainly generated organically but also through strategic acquisitions. The company stands out thanks to its rapid rate

NICE recommends use of Hansa Biopharma’s Idefirix® (imlifidase) as desensitization treatment for highly sensitized kidney transplant patients

· Idefirix® becomes the first and only product recommended by NICE for the desensitization of highly sensitized patients waiting for a kidney transplant1 · NICE considers Idefirix® to be a clinically and cost-effective treatment within current clinical practice · The positive recommendation will enable access to this novel therapy for highly sensitized patients in England, Wales and potentially Northern Ireland Lund, Sweden, June 16, 2022. Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), pioneer in enzyme technology for rare immunological conditions, today announces the

Koskenkorva distillery to run on local wind power